Variant report
Variant | nsv1028760 |
---|---|
Chromosome Location | chr9:1277906-1298566 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:9)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:9 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DMRT2-2 | chr9:1298277-1298431 | XLOC_007263 |
2 | lnc-DMRT2-2 | chr9:1298286-1298431 | XLOC_007263 |
3 | lnc-DMRT2-4 | chr9:1288277-1288431 | l_3725_chr9:1288276-1302899_breast |
4 | lnc-DMRT2-4 | chr9:1289314-1289412 | l_3725_chr9:1288276-1302899_breast |
5 | lnc-DMRT2-2 | chr9:1298277-1298431 | XLOC_007263 |
6 | lnc-DMRT2-2 | chr9:1298277-1298431 | XLOC_007263 |
7 | lnc-DMRT2-2 | chr9:1298276-1298431 | NONHSAT129967 |
8 | lnc-DMRT2-2 | chr9:1298277-1298431 | XLOC_007263 |
9 | lnc-DMRT2-2 | chr9:1298277-1298431 | XLOC_007263 |
No data |
No data |
Variant related genes | Relation type |
---|---|
AP2M1 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546215808 | chr9:1288307-1288308 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs79798711 | chr9:1288318-1288319 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs1538157 | chr9:1288320-1288321 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs542161949 | chr9:1288321-1288322 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs567433669 | chr9:1288360-1288361 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs190913974 | chr9:1288363-1288364 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs556391494 | chr9:1288365-1288366 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs550759219 | chr9:1288398-1288399 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs142973171 | chr9:1288405-1288406 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs181682762 | chr9:1288427-1288428 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs189174584 | chr9:1289314-1289315 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs547453169 | chr9:1289344-1289345 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs200346964 | chr9:1289365-1289366 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs570716048 | chr9:1289394-1289395 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs557135087 | chr9:1297809-1297810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190003028 | chr9:1297850-1297851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34834120 | chr9:1297852-1297853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539446541 | chr9:1297856-1297857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140410362 | chr9:1297876-1297877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34485636 | chr9:1297881-1297882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546557227 | chr9:1297887-1297888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573186248 | chr9:1297922-1297923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542789430 | chr9:1297924-1297925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542126335 | chr9:1297929-1297930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372962085 | chr9:1297935-1297936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559625585 | chr9:1297945-1297946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555947815 | chr9:1297946-1297947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10809852 | chr9:1297949-1297950 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs181641383 | chr9:1297964-1297965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185544932 | chr9:1297980-1297981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188442679 | chr9:1297988-1297989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545793224 | chr9:1298007-1298008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs144257046 | chr9:1298053-1298054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528418005 | chr9:1298066-1298067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548139030 | chr9:1298104-1298105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568254684 | chr9:1298116-1298117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530609587 | chr9:1298134-1298135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs78960426 | chr9:1298143-1298144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs58359592 | chr9:1298149-1298150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573642947 | chr9:1298177-1298178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs180953597 | chr9:1298180-1298181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552967672 | chr9:1298190-1298191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566497870 | chr9:1298196-1298197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs11998942 | chr9:1298223-1298224 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs555739784 | chr9:1298227-1298228 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200627430 | chr9:1298255-1298256 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544475934 | chr9:1298261-1298262 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs1340012 | chr9:1298291-1298292 | Enhancers Active TSS | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs576995325 | chr9:1298345-1298346 | Enhancers Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs565397760 | chr9:1298358-1298359 | Enhancers Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Esophageal cancer | 21851588 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:1297800-1298200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr9:1297800-1298200 | Enhancers | Adipose Nuclei | Adipose |
3 | chr9:1297800-1298400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr9:1298000-1298800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr9:1298200-1300000 | Active TSS | Adipose Nuclei | Adipose |
6 | chr9:1298400-1298800 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |